Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new sibutramine clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on sibutramine
- A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
Status: Completed, Condition Summary: Obesity - A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients.
Status: Active, not recruiting, Condition Summary: Obesity - Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women
Status: Not yet recruiting, Condition Summary: Polycystic Ovary Syndrome - Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Status: Completed, Condition Summary: Breast Cancer - Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
Status: Completed, Condition Summary: Obesity; Hypertension - Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
Status: Completed, Condition Summary: Obesity - A Comparative Study of KES524 in Patients With Obesity Disease
Status: Completed, Condition Summary: Obesity - Treatment of Binge Eating in Obese Patients in Primary Care
Status: Recruiting, Condition Summary: Obesity; Binge Eating - Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects
Status: Terminated, Condition Summary: Obesity; Weight Loss - LOSS- Louisiana Obese Subjects Study
Status: Active, not recruiting, Condition Summary: Obesity - A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Status: Completed, Condition Summary: Overweight; Obesity - A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
Status: Active, not recruiting, Condition Summary: Obesity - Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
Status: Completed, Condition Summary: Obesity - Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
Status: Active, not recruiting, Condition Summary: Cardiovascular Diseases; Heart Diseases; Obesity - Efficacy of MK0557 in Combination With Sibutramine or Orlistat
Status: Completed, Condition Summary: Obesity - Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Status: Active, not recruiting, Condition Summary: Colorectal Neoplasms; Colonic Neoplasms; Rectal Neoplasms - A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
Status: Completed, Condition Summary: Obesity - A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Status: Completed, Condition Summary: Binge Eating Disorder; Obesity - Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss
Status: Completed, Condition Summary: Obesity - Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS
Status: Completed, Condition Summary: Obesity; Polycystic Ovary Syndrome - Adolescent Weight Management Study
Status: Completed, Condition Summary: Protocol #1:Behavioral Therapy + Placebo or Sibutramine; Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food - Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity
Status: Recruiting, Condition Summary: Obesity - A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
Status: Completed, Condition Summary: Obesity - The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
Status: Completed, Condition Summary: Schizophrenia; Psychotic Disorders; Bipolar Disorder - Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
Status: Completed, Condition Summary: Obesity; Overweight